Jan 26, 2021
Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Jan 13, 2021
Precigen Provides Pipeline Updates at the 39th Annual J.P. Morgan Healthcare Conference
Jan 05, 2021
Precigen Announces Clearance of IND to Initiate Phase I Study of PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
Mar 09, 2021 at 7:00 AM EST
Helen Sabzevari, PhD, President and CEO, will present at the H.C. Wainwright Virtual Global Life Sciences Conference and the on-demand webcast will be available starting Tuesday, March 9, 2021 at 7:00 AM ET.